Geisinger’s “warranty” for CABG surgery has gotten a lot of attention, but is it transplantable?
Here are some of the challenges that health insurers face this year
We’ve made strides in increasing the transparency of pricing in the pharmacy supply chain, and now we need to change dispensing behavior
Tougher standards being applied by insurers spur debate about what constitutes true value in a new drug
By assisting doctors, insurers can get all the payment that they are due, but that too often is lost
Mary V. Mason, MD, MBA ; Kara M. House, MBA ; Janice Linehan, PA-C, MHP ; Carol A. Speers, RN ; Lisa M. Joseph, RN, MBA
John A. Marcille
As an idea, Geisinger’s ProvenCare program is a winner. What happens in the marketplace remains to be seen.
Michael L. Millenson
Although federal health agencies support the idea of having pharmacists administer vaccines to their patients, the roadblock continues to be a question of payment
The Formulary Files
Heart valves made from new composite materials minimize calcification, a common problem that can lead to a second valve replacement
Thomas Morrow, MD
Managed Care Outlook